Abstract:Background The most common type of kidney cancer that easily metastasizes is clear cell renal cell carcinoma (ccRCC). The expression levels of hyaluronan-mediated motility receptor (HMMR) in many tumor types are significantly enhanced. HMMR is closely associated with tumor-related progression, treatment resistance, and discouraging prognosis, has yet to be fully investigated in terms of its expression patterns and molecular mechanisms of action in ccRCC. Further research is imperative to elucidate these aspects. Methods We used The Cancer Genome Atlas (TCGA) database to preliminarily investigate HMMR expression and function in ccRCC. We assessed the differential expression level of HMMR between ccRCC cancerous tissues and their matched non-tumor tissues. Subsequently, a series of in vivo and in vitro experiments were designed to elucidate the biological function of HMMR in ccRCC, including Transwell migration assays, CCK-8 assays, clone formation assays and subcutaneous xenograft experiments in nude mice. Through bioinformatics analysis, we identified potential microRNAs (miRNAs) that may regulate HMMR, as well as the possible signaling pathways involved. Finally, we conducted a series of cellular functional experiments to validate our hypotheses regarding the HMMR axis. Results HMMR expression was observably up-regulated in tumor tissues of ccRCC patients, and elevated HMMR expression level showed a strong correlation with ccRCC progression and adverse prognoses of patients. Knocking down HMMR inhibited the proliferative and migratory abilities of ccRCC cells, while its overexpression amplified these oncogenic properties. In nude mouse model, reduced HMMR expression inhibited ccRCC tumor proliferation in vivo. Furthermore, overexpression of an upstream transcriptional regulator, miR-9-5p, effectively downregulated HMMR expression and thus impeded ccRCC cells proliferation and migration. In addition, HMMR might influence ccRCC growth via the Epithelial-Mesenchymal Transition (EMT) pathway and the Janus Kinase1/Signal Transducer and Activator of Transcription1 (JAK1/STAT1) pathway. Conclusions HMMR is overexpressed in ccRCC, and there is a significant link between high HMMR expression and tumor progression, as well as poor patient prognosis. Specifically, HMMR could be targeted and inhibited by miR-9-5p and might modulate the tumorigenesis and progression of ccRCC through both EMT and JAK1/STAT1 signaling pathway.

Mir-9-5p/hmmr Regulates the Tumorigenesis and Progression of Clear Cell Renal Cell Carcinoma Through EMT and JAK1/STAT1 Signaling Pathway

Circular RNA Microarray Expression Profile and Potential Function of Circ0005875 in Clear Cell Renal Cell Carcinoma.

NcRNA-Mediated High Expression of HMMR as a Prognostic Biomarker Correlated With Cell Proliferation and Cell Migration in Lung Adenocarcinoma

Downregulation of Transmembrane Protein 40 by Mir-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma.

High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma.

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key Mirnas

Validating <i>HMMR</i> Expression and Its Prognostic Significance in Lung Adenocarcinoma Based on Data Mining and Bioinformatics Methods

HMMR Promotes Prostate Cancer Proliferation and Metastasis Via AURKA/mTORC2/E2F1 Positive Feedback Loop

Effect of MAP3K8 on Prognosis and Tumor-Related Inflammation in Renal Clear Cell Carcinoma

Mir-19A Correlates with Poor Prognosis of Clear Cell Renal Cell Carcinoma Patients Via Promoting Cell Proliferation and Suppressing PTEN/SMAD4 Expression.

A Comprehensive Investigation Using Meta-Analysis and Bioinformatics on Mir-34A-5p Expression and Its Potential Role in Head and Neck Squamous Cell Carcinoma.

Hsa-miR-9 Methylation Status is Associated with Cancer Development and Metastatic Recurrence in Patients with Clear Cell Renal Cell Carcinoma.

Coupled scRNA-seq and Bulk-seq reveal the role of HMMR in hepatocellular carcinoma

MicroRNA-155-5p Targets NR3C2 to Promote Malignant Progression of Clear Cell Renal Cell Carcinoma

Oncogenic Mir-425-5p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

Data from Mir-200C Targets CDK2 and Suppresses Tumorigenesis in Renal Cell Carcinoma

MicroRNA-19a and Microrna-19B Promote the Malignancy of Clear Cell Renal Cell Carcinoma Through Targeting the Tumor Suppressor RhoB

Oncogene Mir-154-5p Regulates Cellular Function and Acts As a Molecular Marker with Poor Prognosis in Renal Cell Carcinoma

Abstract 3007: Hsa-miR-9 Expression Patterns Are Associated with Metastatic Recurrence in Patients with Clear Cell Renal Cell Carcinoma Through Hypermethylation of the Gene in Tumor Tissue

The Prognostic Value of Mirna-18A-5p in Clear Cell Renal Cell Carcinoma and Its Function Via the Mirna-18A-5p/hif1a/pvt1 Pathway.

Global and Targeted Mirna Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links Mir-155-5p and Mir-210-3p to Both Tumorigenesis and Recurrence.